| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.4 |